The Cancer Vaccine That Could Save Moderna

For years, Moderna was a one-hit wonder, a company that bet everything on mRNA, struck gold with a COVID vaccine and then watched its stock crater as the pandemic faded. Now, the company may have found a way to fight skin cancer. An experimental mRNA-based vaccine succeeded in preventing melanoma (wsj.com/health/pharma/moderna-merck-vaccine-su…)from returning in high-risk patients, sending drug industry stocks (wsj.com/articles/moderna-stock-soars-on-cancer…) soaring. WSJ’s Xavier Martinez (wsj.com/news/author/xavier-martinez?mod=WSJ_TJ…) traces Moderna’s wild ride (wsj.com/health/pharma/moderna-cancer-vaccine-3…) from scrappy startup to the frontier of cancer treatment. Ryan Knutson (wsj.com/news/author/ryan-knutson) hosts.

Further Listening:

- The FDA Commissioner on Vaccines and Public Trust (open.spotify.com/episode/6MagZYmn2H7w2Y5dxOs3F…)

- The Creator of the Record-Setting Covid Vaccine (open.spotify.com/episode/1zwxQiMHATxgueRJBQklW…)

Sign up for WSJ’s free What’s News newsletter (wsj.com/newsletters/whats-news?mod=WSJ_TJPOD).

Learn more about your ad choices. Visit megaphone.fm/adchoices